Inflammation Targeted Curcumin Eye Drops for Treatment OF Dry Eye Disease
DOI:
https://doi.org/10.70130/CAST.2025.8105Keywords:
curcumin argininate-HPβCD, , curcumin argininate, curcumin , EYE Drop, dry eye diseaseAbstract
Dry eye disease (DED) occurs when the eyes do not produce enough tears or when the tears evaporate too quickly because the oil glands are blocked or abnormal. This leads to the eyes drying out and becoming inflamed (red and swollen) and irritated. In North America, DED affects up to 20% of the population. The primary objective of this study was to develop inflammation-targeted curcumin eye drops for the treatment of dry eye disease. Extensive research over the past half-century has shown that curcumin, a component of the golden spice turmeric (Curcuma longa), has pleiotropic activities that emanate from its ability to modulate numerous signaling molecules, such as proinflammatory cytokines, apoptotic proteins, NF–κB, cyclooxygenase 2, 5LOX, STAT3, C-reactive protein, prostaglandin E, prostate-specific antigen, adhesion molecules, phosphorylase kinase, transforming growth factor β, triglyceride, ET1, and creatinine in human participants. To enhance the solubility of curcumin, it was complexed with arginine. Furthermore, curcumin and curcumin argininate were complexed with HPβCD by freeze-drying and characterized by fluorescence spectral studies, FTIR, differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). The formulations were reconstituted with PBS 6.8, and the curcumin and curcumin arginate contents in the inclusion complex were 85.96 and 87%, respectively. The curcumin- and curcumin argininate-HPβCD eye drops were clear and free of particulate matter, and the pH of the formulations was 6.8, suggesting that the formulation can be well tolerated in the eyes, as the pH of tear fluid is also 6.8.
References
Rohit, A., Willcox, M., & Stapleton, F. (2013). Tear lipid layer and contact lens comfort: A review. Eye and Contact Lens, 39(3), 247–253. https://doi.org/10.1097/ICL.0b013e31828af164
Achtsidis, V., Kozanidou, E., Bournas, P., Tentolouris, N., & Theodossiadis, P. G. (2014). Dry eye and clinical disease of tear film, diagnosis, and management. US. Ophthalmic Review, 7(2), 109–115. https://doi.org/10.17925/USOR.2014.07.02.109
Alwan, M. R., Al-Dubai SAR, Al-Naggar, Baobaid M, Mohammed M, Abdulghani M. The effect of Curcumin and tocotrienol on the development of eye disease. J Applied Pharmaceutical Sci 2012;1:1-7.
Al-Zein, H., Sakeer, K., & Alanazi, F. K. (2011). Designing an extended release waxy matrix tablet containing nicardipine-hydroxypropyl β cyclodextrin complex. Saudi Pharmaceutical Journal, 19(4), 245–253. https://doi.org/10.1016/j.jsps.2011.05.004
Banerjee, A., Moore, E. E., McLaughlin, N. J., Lee, L., Jones, W. L., Johnson, J. L., Nydam, T. L., & Silliman, C. C. (2013). Hyperosmolarity attenuates TNF-α-mediated proinflammatory activation of human pulmonary microvascular endothelial cells. Shock, 39(4), 366–372. https://doi.org/10.1097/SHK.0b013e3182894016
Barabino, S., Chen, Y., Chauhan, S., & Dana, R. (2012). Ocular surface immunity homeostatic mechanisms and their disruption in dry eye disease. Progress in Retinal and Eye Research, 31(3), 271–285. https://doi.org/10.1016/j.preteyeres.2012.02.003
Butovich, I. A., Millar, T. J., & Ham, B. M. (2008). Understanding and analyzing meibomian lipids A review. Current Eye Research, 33(5), 405–420. https://doi.org/10.1080/02713680802018419
Chen, Y. R., & Tan, T. H. (1998). Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene, 17(2), 173–178. https://doi.org/10.1038/sj.onc.1201941
Foster, C. S., & Sheppard, J. D. (2010). Dry eye syndrome: Practice essentials, background, anatomy. Medscape Drugs, Disrase and Procedures, 1, 1–5.
Henderson, R., & Madden, L. (2013). Dry eye management. Optometry in Practice, 14, 137–146.
Jain, D., Carvalho, E., & Banerjee, R. (2010). Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomaterialia, 6(4), 1370–1379. https://doi.org/10.1016/j.actbio.2009.11.001
Jain, D., Carvalho, E., Banthia, A. K., & Banerjee, R. (2011). Development of polyvinyl alcohol-gelatin membranes for antibiotic delivery in the eye. Drug Development and Industrial Pharmacy, 37(2), 167–177. https://doi.org/10.3109/03639045.2010.502533
Javadi, M.-A., & Feizi, S. (2011). Dry eye syndrome. Journal of Ophthalmic and Vision Research, 6(3), 192–198.
Kulshrestha, O. P., Talwar, P., & Mathur, M. (1984). Tear film breakup time (B.U.T.) in sub clinical dry eyes. Indian Journal of Ophthalmology, 32(5), 454–455.
Lemp, M. A., & Foulks, G. N. (2007). International Dry Eye Workshop. 2008. The definition and classification of dry eye disease guidelines, 151, 792–797.
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005). Cyclodextrins in drug delivery. Expert Opinion on Drug Delivery, 2(2), 335–351. https://doi.org/10.1517/17425247.2.1.335
Narayanan, S., Miller, W. L., & McDermott, A. M. (2003). Expression of human β-Defensins in conjunctival epithelium: Relevance to dry eye disease. Investigative Ophthalmology and Visual Science, 44(9), 3795–3801. https://doi.org/10.1167/iovs.02-1301
Nichols, J. J., Ziegler, C., Mitchell, G. L., & Nichols, K. K. (2005). Self-reported dry eye disease across refractive modalities. Investigative Ophthalmology and Visual Science, 46(6), 1911–1914. https://doi.org/10.1167/iovs.04-1294
Pencer, P., Thornton, M. D., & Troyer, E. (2006). Dry eye: Inflammation and nutrition, dry eye: A practical guide to ocular surface disorders. Ophthalmic ASC, 1–6.
Pescosolido, N., Giannotti, R., Plateroti, A. M., Pascarella, A., & Nebbioso, M. (2014). Curcumin: Therapeutical potential in ophthalmology. Planta Medica, 80(4), 249–254. https://doi.org/10.1055/s-0033-1351074
Stephen, C. P., Geerling, G., Kinoshita, S., Lemp, M. A., Culley, M. J., Nelson, D., Novack, G. N., & Wilson, C. (2007). Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the international dry eye work shop 2007. The Ocular Surface, 5(2), 163–178. https://doi.org/10.1016/s1542-0124(12)70085-x
Tong, L., Petznick, A., Lee, S. Y., & Tan, J. (2012). Assessment and management of dry eye patients for non-ophthalmic health care practitioners. Proceedings of Singapore Healthcare, 21(1), 15–22. https://doi.org/10.1177/201010581202100104
Uchino, M., & Schaumberg, D. A. (2013). Dry eye disease: Impact on quality of life and vision. Current Ophthalmology Reports, 1(2), 51–57. https://doi.org/10.1007/s40135-013-0009-1
Published
Issue
Section
How to Cite
